Central Neurotranspeptide, Alpha-Melanocyte-Stimulating Hormone (.ALPHA.-MSH) is Upregulated in Patients with Congestive Heart Failure
- 1 January 2006
- journal article
- Published by Japanese Society of Internal Medicine in Internal Medicine
- Vol. 45 (7) , 429-434
Abstract
Alpha-melanocyte-stimulating hormone (alpha-MSH), a pro-opiomelanocortin (POMC) derivative, is a neuropeptide with potent anti-inflammatory properties that inhibits tissue injury in a wide array of inflammation models. To determine if alpha-MSH is involved in the development of congestive heart failure (CHF) with the specific aim of examining its peripheral source and one of the mechanisms. The circulating levels of alpha-MSH were measured in 115 patients with CHF using a double-antibody radioimmunoassay. To determine one of the sources of circulating alpha-MSH, human peripheral blood mononuclear cells (PBMC) were stimulated with lipopolysaccharide (LPS) or tumor necrosis factor (TNF)-alpha. Furthermore, to clarify one of the functions of alpha-MSH, PBMC were cultured in the presence or absence of alpha-MSH. Plasma levels of alpha-MSH were significantly higher in NYHA class II patients with CHF than in control subjects (p<0.0001). A significant correlation was found between the levels of alpha-MSH and high-sensitive testing for C-reactive protein in patients with CHF (r=0.41, p<0.0005). PBMC stimulated with LPS or TNF-alpha released alpha-MSH in a concentration-dependent manner. alpha-MSH inhibited LPS-induced TNF-alpha production, and alpha-MSH simultaneously augmented production of interleukin (IL)-10 by PBMC. Circulating alpha-MSH was increased in patients with CHF. Inflammatory response induced alpha-MSH production in cultured human PBMC. Treatment of alpha-MSH could modify the immunobalance between inflammatory and anti-inflammatory responses in cultured PBMC. These findings suggest that alpha-MSH may play an important role in the pathophysiology of CHF.Keywords
This publication has 29 references indexed in Scilit:
- Inflammatory Mediators and the Failing HeartCirculation Research, 2002
- Plasma concentrations and anti-L-cytokine effects of α-melanocyte stimulating hormone in septic patientsCritical Care Medicine, 2000
- Anti-inflammatory actions of the neuroimmunomodulator α-MSHImmunology Today, 1997
- Circulating Levels of Cytokines and Their Endogenous Modulators in Patients With Mild to Severe Congestive Heart Failure Due to Coronary Artery Disease or HypertensionJACC, 1996
- Increased circulating cytokines in patients with myocarditis and cardiomyopathy.Heart, 1994
- Characterization of β-endorphin- and α-MSH-related peptides in rat heartPeptides, 1993
- alpha-Melanocyte stimulating hormone in the modulation of host reactionsEndocrine Reviews, 1993
- Production of Immunosuppressing Melanotropins By Human KeratinocytesaAnnals of the New York Academy of Sciences, 1993
- Proopiomelanocortin‐Derived Peptides and mRNA Are Expressed in Rat HeartAnnals of the New York Academy of Sciences, 1993
- Negative Inotropic Effects of Cytokines on the Heart Mediated by Nitric OxideScience, 1992